PHIO PHARMACEUTICALS CORP. Reclassifications of Temporary to Permanent Equity
PHIO PHARMACEUTICALS CORP. (PHIO) reported Reclassifications of Temporary to Permanent Equity of $2.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-30.
Discontinued › Shareholders' Equity
us-gaap:ReclassificationsOfTemporaryToPermanentEquity · last filed 2017-03-30
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for the quarter ending 2015-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for the quarter ending 2015-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for the quarter ending 2015-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for the quarter ending 2015-03-31 was $2.00M, a 33.33% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for fiscal 2015 was $2.00M, a 33.33% decline from fiscal 2014.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for fiscal 2014 was $3.00M, a 50.00% increase from fiscal 2013.
- PHIO PHARMACEUTICALS CORP. reclassifications of temporary to permanent equity for fiscal 2013 was $2.00M.
| Period end | Reclassifications of Temporary to Permanent Equity 3 month | Reclassifications of Temporary to Permanent Equity 6 month | Reclassifications of Temporary to Permanent Equity 9 month | Reclassifications of Temporary to Permanent Equity 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $0.00 derived: sum of 3 quarters · filed 2017-03-30 | $2.00M 10-K · filed 2017-03-30 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $2.00M 10-Q · filed 2015-11-12 | $2.00M derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $2.00M 10-Q · filed 2015-08-12 | $2.00M derived: sum of 3 quarters · filed 2016-03-30 | $2.00M derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-03-31 | $2.00M 10-Q · filed 2015-05-13 | $2.00M derived: sum of 2 quarters · filed 2016-03-30 | $2.00M derived: sum of 3 quarters · filed 2016-03-30 | $2.00M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $3.00M 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $3.00M 10-Q · filed 2015-11-12 | $3.00M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $3.00M 10-Q · filed 2015-08-12 | $3.00M derived: sum of 3 quarters · filed 2015-08-12 | |
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-13 | $3.00M derived: sum of 2 quarters · filed 2015-05-13 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $2.00M 10-K · filed 2015-03-30 | ||
| 2013-09-30 | $2.00M 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |